Item 2.02 Results of Operation and Financial Condition
On January 10, 2022, MiMedx Group, Inc. (the "Company") issued a press release
and presentation described further in Item 7.01 of this Current Report on Form
8-K (this "Current Report") providing certain unaudited preliminary financial
results for the full year ended December 31, 2021.
Item 7.01 Regulation FD
Beginning on Monday, January 10, 2022, Timothy R. Wright, MiMedx Chief Executive
Officer, and Peter M. Carlson, MiMedx Chief Financial Officer, are expected to
meet with investors and, on January 12, 2022, present at the 40th Annual J.P.
Morgan Healthcare Conference on behalf of the Company, beginning at 5:15 p.m.
Eastern Time. A copy of the presentation they will use is furnished as Exhibit
99.1 to this Current Report and is incorporated herein by reference. The live
webcast may be accessed on the Events page of the Investors section of the
Company's website or by clicking here.
In addition, the Company also issued a press release on January 10, 2022,
announcing its expectations as to certain financial and other results for the
year ending December 31, 2022, which are also set forth in the presentation. A
copy of the press release is furnished as Exhibit 99.2 to this Current Report
and is incorporated herein by reference.
The information in this Current Report, including Exhibits 99.1 and 99.2, shall
not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended, or otherwise subject to the liabilities of that section,
nor shall such information be deemed incorporated by reference in any filing
under the Securities Act of 1933, as amended, except as expressly set forth by
specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. Description of Exhibit
99.1 Slide Presentation dated January 10, 2022
99.2 Press release dated January 10, 2022
The cover page from this Current Report on Form 8-K, formatted in Inline
© Edgar Online, source Glimpses